| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,284 |
10,439 |
$1.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,633 |
10,251 |
$722K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,972 |
3,410 |
$319K |
| 99199 |
Unlisted special service, procedure or report |
45,215 |
26,012 |
$254K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,753 |
2,371 |
$235K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,837 |
2,506 |
$223K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
811 |
128 |
$174K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,834 |
1,648 |
$145K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,319 |
6,341 |
$129K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,796 |
3,316 |
$110K |
| D0145 |
Oral evaluation for a patient under three years of age |
2,217 |
1,965 |
$62K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
295 |
220 |
$62K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
395 |
334 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,505 |
2,203 |
$30K |
| 99401 |
|
1,242 |
781 |
$28K |
| D1206 |
Topical application of fluoride varnish |
2,229 |
1,973 |
$28K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,707 |
3,285 |
$25K |
| 96160 |
|
6,701 |
5,843 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
246 |
225 |
$20K |
| 92567 |
|
1,681 |
1,284 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,479 |
701 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
554 |
487 |
$18K |
| 90474 |
|
943 |
870 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,035 |
955 |
$17K |
| 90651 |
|
977 |
841 |
$15K |
| 83655 |
|
658 |
604 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
85 |
76 |
$8K |
| 94010 |
|
251 |
199 |
$5K |
| 96161 |
|
1,515 |
1,301 |
$5K |
| 99070 |
|
738 |
613 |
$5K |
| 81003 |
|
4,399 |
3,751 |
$4K |
| 92551 |
|
6,808 |
5,874 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
350 |
308 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
18 |
14 |
$3K |
| 90734 |
|
934 |
782 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
170 |
109 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
39 |
37 |
$2K |
| 82465 |
|
445 |
403 |
$2K |
| 0071A |
|
52 |
26 |
$1K |
| 85018 |
|
1,738 |
1,507 |
$1K |
| 94664 |
|
110 |
96 |
$979.44 |
| 90621 |
|
881 |
751 |
$946.26 |
| 99173 |
|
7,131 |
6,143 |
$843.54 |
| 0072A |
|
38 |
18 |
$658.24 |
| 36410 |
|
51 |
43 |
$567.40 |
| 90715 |
|
372 |
321 |
$409.85 |
| G9919 |
Screening performed and positive and provision of recommendations |
17 |
13 |
$375.60 |
| 90686 |
|
1,807 |
1,619 |
$265.56 |
| 36415 |
Collection of venous blood by venipuncture |
74 |
62 |
$159.30 |
| 95115 |
|
21 |
20 |
$146.53 |
| 91307 |
|
112 |
52 |
$38.55 |
| 90688 |
|
52 |
45 |
$16.35 |
| 90633 |
|
833 |
754 |
$0.00 |
| 90710 |
|
832 |
737 |
$0.00 |
| 90648 |
|
798 |
733 |
$0.00 |
| 99072 |
|
2,376 |
2,137 |
$0.00 |
| 90670 |
|
1,610 |
1,441 |
$0.00 |
| 90685 |
|
199 |
191 |
$0.00 |
| 90700 |
|
193 |
167 |
$0.00 |
| 90707 |
|
13 |
13 |
$0.00 |
| 90713 |
|
18 |
18 |
$0.00 |
| 90698 |
|
626 |
573 |
$0.00 |
| 90680 |
|
991 |
910 |
$0.00 |
| 90744 |
|
140 |
126 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
329 |
289 |
$0.00 |
| 90723 |
|
185 |
179 |
$0.00 |
| 90696 |
|
183 |
159 |
$0.00 |